Steve H. Marshall

1.5k total citations
18 papers, 930 citations indexed

About

Steve H. Marshall is a scholar working on Molecular Medicine, Infectious Diseases and Pharmacology. According to data from OpenAlex, Steve H. Marshall has authored 18 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 7 papers in Infectious Diseases and 5 papers in Pharmacology. Recurrent topics in Steve H. Marshall's work include Antibiotic Resistance in Bacteria (12 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Steve H. Marshall is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Steve H. Marshall collaborates with scholars based in United States, Colombia and Myanmar. Steve H. Marshall's co-authors include Louis B. Rice, Rebecca Hutton‐Thomas, Robert A. Salata, Robert A. Bonomo, Curtis J. Donskey, Andrea M. Hujer, Kristine M. Hujer, Lenore L. Carias, Christine Lascols and D. J. Hoban and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Steve H. Marshall

18 papers receiving 886 citations

Peers

Steve H. Marshall
Steve H. Marshall
Citations per year, relative to Steve H. Marshall Steve H. Marshall (= 1×) peers Apostolos Liakopoulos

Countries citing papers authored by Steve H. Marshall

Since Specialization
Citations

This map shows the geographic impact of Steve H. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve H. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve H. Marshall more than expected).

Fields of papers citing papers by Steve H. Marshall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve H. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve H. Marshall. The network helps show where Steve H. Marshall may publish in the future.

Co-authorship network of co-authors of Steve H. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Steve H. Marshall. A scholar is included among the top collaborators of Steve H. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve H. Marshall. Steve H. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Choe, Hyonmin, Joscelyn M. Tatro, Kristine M. Hujer, et al.. (2022). Staphylococcus aureus and Acinetobacter baumannii Inhibit Osseointegration of Orthopedic Implants. Infection and Immunity. 90(3). e0066921–e0066921. 12 indexed citations
2.
Mills, John, Laura J. Rojas, Steve H. Marshall, et al.. (2021). Risk Factors for and Mechanisms of COlistin Resistance Among Enterobacterales: Getting at the CORE of the Issue. Open Forum Infectious Diseases. 8(7). ofab145–ofab145. 8 indexed citations
3.
Barnes, Melissa D., Vijay Kumar, Christopher R. Bethel, et al.. (2019). Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent. mBio. 10(2). 95 indexed citations
4.
Richter, Sandra S., Eric Cober, Laura J. Rojas, et al.. (2018). Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins. Diagnostic Microbiology and Infectious Disease. 91(1). 89–92. 12 indexed citations
5.
Henig, Oryan, Eric Cober, Sandra S. Richter, et al.. (2017). A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant Enterobacteriaceae. Open Forum Infectious Diseases. 4(3). ofx157–ofx157. 22 indexed citations
6.
Rojas, Laura J., Madiha Salim, Eric Cober, et al.. (2016). Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality. Clinical Infectious Diseases. 64(6). 711–718. 150 indexed citations
7.
Iovleva, Alina, Federico Pérez, Steve H. Marshall, et al.. (2016). Ceftazidime/Avibactam and Ceftolozane/Tazobactam in Treatment of Pulmonary Infections by Imipenem Resistant Pseudomonas aeruginosa. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations
8.
Samuel, Sophie, Laura J. Rojas, Susan D. Rudin, et al.. (2016). Ceftazidime-Avibactam for the Treatment of Post-Neurosurgical Meningitis Caused by a Klebsiella pneumoniae carbapenemase (KPC)-Producing Klebsiella pneumoniae. Open Forum Infectious Diseases. 3(suppl_1). 16 indexed citations
9.
Viau, Roberto, Andrea M. Hujer, Steve H. Marshall, et al.. (2012). "Silent" Dissemination of Klebsiella pneumoniae Isolates Bearing K. pneumoniae Carbapenemase in a Long-term Care Facility for Children and Young Adults in Northeast Ohio. Clinical Infectious Diseases. 54(9). 1314–1321. 65 indexed citations
10.
Lascols, Christine, Meredith Hackel, Steve H. Marshall, et al.. (2011). Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009). Journal of Antimicrobial Chemotherapy. 66(9). 1992–1997. 137 indexed citations
11.
Lobritz, Michael A., Rebecca Hutton‐Thomas, Steve H. Marshall, & Louis B. Rice. (2003). Recombination Proficiency Influences Frequency and Locus of Mutational Resistance to Linezolid in Enterococcus faecalis. Antimicrobial Agents and Chemotherapy. 47(10). 3318–3320. 57 indexed citations
12.
Marshall, Steve H., Curtis J. Donskey, Rebecca Hutton‐Thomas, Robert A. Salata, & Louis B. Rice. (2002). Gene Dosage and Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrobial Agents and Chemotherapy. 46(10). 3334–3336. 206 indexed citations
13.
Rice, Louis B., Lenore L. Carias, & Steve H. Marshall. (1995). Tn5384, a composite enterococcal mobile element conferring resistance to erythromycin and gentamicin whose ends are directly repeated copies of IS256. Antimicrobial Agents and Chemotherapy. 39(5). 1147–1153. 32 indexed citations
14.
Carias, Lenore L., et al.. (1995). Tn5384, an IS256-based composite mobile element in Enterococcus faecalis.. PubMed. 85. 71–5. 2 indexed citations
15.
Þórisdóttir, Anna Sesselja, Lenore L. Carias, Steve H. Marshall, et al.. (1994). IS6770, An Enterococcal Insertion-Like Sequence Useful For Determining The Clonal Relationship Of Clinical Enterococcal Isolates. The Journal of Infectious Diseases. 170(6). 1539–1548. 33 indexed citations
16.
Rice, Louis B. & Steve H. Marshall. (1994). Insertions of IS256-like element flanking the chromosomal beta-lactamase gene of Enterococcus faecalis CX19. Antimicrobial Agents and Chemotherapy. 38(4). 693–701. 28 indexed citations
17.
Rice, Louis B., Steve H. Marshall, Lenore L. Carias, Lorraine Sutton, & George A. Jacoby. (1993). Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes. Antimicrobial Agents and Chemotherapy. 37(12). 2760–2761. 30 indexed citations
18.
Rice, Louis B. & Steve H. Marshall. (1992). Evidence of incorporation of the chromosomal beta-lactamase gene of Enterococcus faecalis CH19 into a transposon derived from staphylococci. Antimicrobial Agents and Chemotherapy. 36(9). 1843–1846. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026